Bridge Life Sciences Raises $110M to Advance Drug Development Pipeline
- 1 hour ago
- 1 min read
Duluth, GA, August 12, 2026 (Yahoo Finance) -- Bridge Life Sciences has raised $110 million in new financing to support the advancement of its therapeutic pipeline. The company plans to use the capital to accelerate development programs and strengthen its research and clinical capabilities. The financing provides additional resources to support the company’s growth and progress toward future clinical milestones.
Read full article here.






















Comments